A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases

被引：0
|
作者：
Lauren E. Abrey
Jon D. Olson
Jeffrey J. Raizer
Michelle Mack
Ann Rodavitch
Dina Y. Boutros
Mark G. Malkin
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Neurology
来源：
Journal of Neuro-Oncology | 2001年 / 53卷
关键词：
brain metastases; chemotherapy; lung cancer; temozolomide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Treatment options for patients with recurrent brain metastases are extremely limited. This study was designed to determine the safety and efficacy of temozolomide in the treatment of recurrent or progressive brain metastases.
引用
收藏
页码：259 / 265
页数：6
相关论文
共 50 条
  • [21] Temozolomide in recurrent/progressive oligodendroglioma and oligoastrocytoma:: A phase II study
    Soffietti, R
    Costanza, A
    Nobile, M
    Rudà, R
    Mutani, R
    NEUROLOGY, 2002, 58 (07) : A14 - A14
  • [22] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    Bower, M
    Newlands, ES
    Bleehen, NM
    Brada, M
    Begent, RJH
    Calvert, H
    Colquhoun, I
    Lewis, P
    Brampton, MH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) : 484 - 488
  • [23] Phase II trial of temozolomide in patients with progressive low-grade glioma
    Quinn, JA
    Reardon, DA
    Friedman, AH
    Rich, JN
    Sampson, JH
    Provenzale, JM
    McLendon, RE
    Gururangan, S
    Bigner, DD
    Herndon, JE
    Avgeropoulos, N
    Finlay, J
    Tourt-Uhlig, S
    Affronti, ML
    Evans, B
    Stafford-Fox, V
    Zaknoen, S
    Friedman, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 646 - 651
  • [24] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    M. Bower
    E. S. Newlands
    N. M. Bleehen
    M. Brada
    R. J. H. Begent
    H. Calvert
    I. Colquhoun
    P. Lewis
    M. H. Brampton
    Cancer Chemotherapy and Pharmacology, 1997, 40 : 484 - 488
  • [25] A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy
    Dixit, Karan
    Singer, Lauren
    Grimm, Sean Aaron
    Lukas, Rimas V.
    Schwartz, Margaret A.
    Rademaker, Alfred
    Zhang, Hui
    Kocherginsky, Masha
    Chernet, Sofia
    Sharp, Laura
    Nelson, Valerie
    Raizer, Jeffrey J.
    Kumthekar, Priya
    CANCERS, 2024, 16 (11)
  • [26] Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
    Christodoulou, C
    Bafaloukos, D
    Kosmidis, P
    Samantas, E
    Bamias, A
    Papakostas, P
    Karabelis, A
    Bacoyiannis, C
    Skarlos, DV
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 249 - 254
  • [27] A phase II study of radiosurgery and temozolomide for patients with one to four brain metastases
    Fiveash, J. B.
    Sawrie, S. M.
    Guthrie, B. L.
    Spencer, S. A.
    Meredith, R. F.
    Markert, J. M.
    Nordal, R. A.
    Conry, R. M.
    Nabors, L. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] PHASE II TRIAL OF TEMOZOLOMIDE AND REIRRADIATION USING CONFORMAL RADIOTHERAPY IN RECURRENT BRAIN GLIOMAS
    Osman, M. A.
    ANNALS OF ONCOLOGY, 2013, 24
  • [29] Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma
    Schaff, Lauren
    Fortunato, John
    Grommes, Christian
    Gavrilovic, Igor T.
    Lin, Andrew
    Pentsova, Elena
    Miller, Alex
    Newton, Adam
    Gonzalez, Ashley
    Mellinghoff, Ingo K.
    Kaley, Thomas Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] A PHASE II TRIAL OF SORAFENIB (NEXAVAR) AND PROTRACTED TEMOZOLOMIDE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
    Reardon, David
    Desjardins, Annick
    Vredenburgh, James
    Friedman, Allan
    Sampson, John
    Gururangan, Sridharan
    Rich, Jeremy
    Friedman, Henry
    NEURO-ONCOLOGY, 2008, 10 (05) : 839 - 839
12345